Anthony Whetton, PhD

Tony is the trailblazer behind cutting edge work on proteomics for human and animal health, accelerating biomarker discoveries to enable patients to be treated in an individual way, at the right time, for the best outcome.

Tony originally trained in biochemistry before pursuing research in hematology and stem cell biology, successfully pioneering new mass spectrometry techniques and state-of-the-art facilities. His research then expanded and developed to include clinical proteomics research to discover new biomarkers associated with cancers.

Under his expert leadership at the Stoller Biomarker Discovery Centre (founded in partnership with SCIEX), researchers used mass spectrometry and antibody-based techniques with allied informatics and molecular pathology support to devise new algorithms and approaches for precision medicine. 

In 2021 Tony joined the University of Surrey School of Veterinary Medicine and the School of Life Sciences and Health. He is now applying his proteomics platform combined with artificial intelligence in collaboration with colleagues at University of Surrey and in industry to improve human and animal health.

“We aim to find protein markers in the blood that could be used to stop patients being given treatments which won’t improve their condition. These markers will be developed to ensure doctors can prescribe the right treatment for the right patient as early as possible. The platform developed is a major step forward in precision medicine and the future of healthcare for both humans and animals.”

Anthony Whetton